Clinically Isolated Syndrome (CIS) Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Clinically Isolated Syndrome (CIS) Market is segmented By Treatment (Systemic Treatments, Primary Therapy, Primary Therapy, Recurrence Therapy, Recurrence Therapy), By Emerging Drugs, (Olvimulogene nanivacirepvec, Rucaparib), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Clinically Isolated Syndrome (CIS) Market is segmented By Treatment (Systemic Treatments, Primary Therapy, Primary Therapy, Recurrence Therapy, Recurr....

Clinically Isolated Syndrome (CIS) Market Size

Market Size in USD

CAGR6.7%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	6.7%
Market Concentration	High
Major Players	NIHON KOHDEN CORPORATION, Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Siemens Healthcare Private Limited, Natus Medical Incorporated

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Clinically Isolated Syndrome (CIS) Market Analysis

The clinically isolated syndrome (CIS) market is estimated to be valued at USD 16.03 Bn in 2024 and is expected to reach USD 25.19 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031. The market is driven by rising prevalence of multiple sclerosis and growing awareness about early diagnosis and treatment of the CIS condition to delay progression to multiple sclerosis.

Clinically Isolated Syndrome (CIS) Market Report Snapshots

Buy Now